Radiotracers could improve choice of bladder cancer therapies

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
Managed Healthcare Executive

Detalimogene gene therapy shows promising results in bladder cancer trial

An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...
Purdue University

One Health: A ‘digital twin’ model for predicting cancer outcomes

WEST LAFAYETTE, Ind. — The striking similarities between invasive bladder cancer in dogs and humans have fueled research advances for more than three decades. Most of that work has looked at separate ...
WebMD

Zusduri for Bladder Cancer

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...
WebMD

Transurethral Resection of Bladder Tumor (TURBT)

What Is Transurethral Resection of Bladder Tumor (TURBT)? If you have bladder cancer or suspected bladder cancer, your doctor has probably told you that you need a transurethral resection of the ...
Targeted Oncology

A Paradigm Shift in Bladder Cancer: Dr Jacob on the FDA Approval of TAR-200

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...